Jesus D Anampa (Jesus Anampa, Jesus M Anampa)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 13

Top Venues

Breast cancer research and treatment

Science translational medicine

Expert opinion on pharmacotherapy

NPJ breast cancer

Montefiore Einstein Center for Cancer Care

Yeshiva University Albert Einstein College of Medicine (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Montefiore Einstein Center for Cancer Care

United States

Breast Medical Oncology attending :: Medical Oncology

Education History

Yeshiva University Albert Einstein College of Medicine Jul 01 2016

United States

MSC :: Medical School

Publications

Walter H Carbajal-Ochoa, Devin Johnson, Alvaro Alvarez, Ana M Bernal, Jesus D Anampa
Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer. Breast cancer research and treatment (2023)
Walter Carbajal-Ochoa, Daniela C Bravo-Solarte, Ana M Bernal, Jesus D Anampa
Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer. Breast cancer research and treatment (2023)
Jin-Yu Lu, Alvaro Alvarez Soto, Jesus D Anampa
The landscape of systemic therapy for early stage triple-negative breast cancer. Expert opinion on pharmacotherapy 23 (11) (2022)
Alvaro Alvarez, Ana M Bernal, Jesus D Anampa
Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Breast cancer research and treatment 198 (1) (2022)
Alvaro Alvarez, Ana M Bernal, Jesus D Anampa
Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Breast cancer research and treatment 198 (1) (2022)
Alvaro Alvarez, Ana M Bernal, Jesus D Anampa
Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Breast cancer research and treatment 198 (1) (2022)
George S Karagiannis, Anthony Bianchi, Luis Rivera Sanchez, Kamal Ambadipudi, Min-Hui Cui, Jesus D Anampa, Saeed Asiry, Yarong Wang, Allison S Harney, Jessica M Pastoriza, Yu Lin, Xiaoming Chen, Joan G Jones, David Entenberg, Dana Haddad, Laura J Hodges, Timothy Q Duong, Joseph A Sparano, Maja H Oktay, Craig A Branch, John S Condeelis
Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy. NPJ breast cancer 8 (1) (2022)
Alvaro Alvarez, Ana M Bernal, Jesus D Anampa
Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Breast cancer research and treatment 198 (1) (2022)
Alvaro Alvarez, Ana M Bernal, Jesus D Anampa
Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Breast cancer research and treatment (2022)
Carolina Bernabe, Ana I Velazquez, Coral Olazagasti, Cristiane Decat Bergerot, Paulo Gustavo Bergerot, José F Corona-Cruz, Ivy Riano, Christina Adaniel, Francisca Ramirez, Jesus D Anampa, Carmen Cajina, Evelin Mena, Elias Gracia, Alvaro Menendez, Henry Idrobo, Raimundo Bezares, Omar Orlando Castillo Fernandez, Liseth Duque, Luis Corrales-Rodríguez, Glenda Ramos, Alba J Kihn-Alarcón, Ilana Schlam, Ximena Jordan Bruno, Gerardo A Umanzor, Jenny Lissette Castro, Federico Losco, Luis Ubillos, Eduardo Richardet, Enrique Soto Pérez de Celis, Narjust Florez, null null
HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America. JCO global oncology 8 (2022)
Luis A Carvajal, Daniela Ben Neriah, Adrien Senecal, Lumie Benard, Victor J Thiruthuvanathan, Tatyana Yatsenko, Swathi-Rao Narayanagari, Justin C Wheat, Tihomira I Todorova, Kelly Mitchell, Charles Kenworthy, Vincent Guerlavais, D Allen Annis, Boris Bartholdy, Britta Will, Jesus D Anampa, Ioannis Mantzaris, Manuel Aivado, Robert H Singer, Robert A Coleman, Amit Verma, Ulrich Steidl
Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia. Science translational medicine 10 (436) (2019)
George S Karagiannis, Jessica M Pastoriza, Yarong Wang, Allison S Harney, David Entenberg, Jeanine Pignatelli, Ved P Sharma, Emily A Xue, Esther Cheng, Timothy M D'Alfonso, Joan G Jones, Jesus D Anampa, Thomas E Rohan, Joseph A Sparano, John S Condeelis, Maja H Oktay
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism. Science translational medicine 9 (397) (2018)
Jesus D Anampa, Joseph A Sparano
New agents for the management of resistant metastatic breast cancer. Expert opinion on pharmacotherapy 18 (17) (2017)

Jesus D Anampa.css-eqlu8i{font-size:small;padding-left:4px;} (Jesus Anampa, Jesus M Anampa)

Publication Activity (10 Years)

Top Topics

Top Venues

Jesus D Anampa (Jesus Anampa, Jesus M Anampa)